```

[Congressional Bills 104th Congress]
[From the U.S. Government Publishing Office]
[H.R. 1721 Introduced in House (IH)]

  1st Session
                                H. R. 1721

    To amend the Public Health Service Act to provide for programs 
                       regarding ovarian cancer.

_______________________________________________________________________

                    IN THE HOUSE OF REPRESENTATIVES

                              May 25, 1995

 Mrs. Mink of Hawaii introduced the following bill; which was referred 
                      to the Committee on Commerce

_______________________________________________________________________

                                 A BILL

 
    To amend the Public Health Service Act to provide for programs 
                       regarding ovarian cancer.
    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Ovarian Cancer Research and 
Information Amendments of 1995''.

SEC. 2. FUNDING FOR RESEARCH ON OVARIAN CANCER.

    Section 417B(b)(2) of the Public Health Service Act, as added by 
section 403 of Public Law 103-43, is amended--
            (1) by striking ``cancers.--For the purpose of'' and all 
        that follows through ``417,'' and inserting the following: 
        ``cancers.--
                    ``(A) For the purpose of carrying out section 
                417(d),''; and
            (2) by adding at the end the following subparagraph:
                    ``(B)(i) For the purpose of carrying out research 
                under section 417(d) on ovarian cancer, there are 
                authorized to be appropriated $90,000,000 for fiscal 
                year 1996, and such sums as may be necessary for each 
                of the fiscal years 1997 and 1998. With respect to such 
                purpose, such authorizations of appropriations are in 
                addition to the authorizations of appropriations 
                established in subparagraph (A) and in subsection (a).
                    ``(ii) Of the amounts appropriated under clause 
                (i), the Director of the Institute shall reserve 50 
                percent for research described in such clause that does 
                not involve treatment or clinical trials, and 50 
                percent for research described in such clause that does 
                involve treatment and clinical trials.
                    ``(iii) In expending the amounts reserved under 
                clause (ii), the Director of the Institute shall ensure 
                that 1 or more programs of research on ovarian cancer 
                are carried out under the programs designated by the 
                Director as the Specialized Programs of Research 
                Excellence.''.

SEC. 3. PUBLIC INFORMATION AND EDUCATION ON OVARIAN CANCER.

    Section 417(d)(4) of the Public Health Service Act, as added by 
section 401 of Public Law 103-43, is amended by striking ``section 413; 
and'' and inserting the following: ``section 413, which programs shall 
include programs on ovarian cancer that (subject to changes in the 
applicable facts) provide information and education regarding--
                    ``(A) screening procedures for such cancer, 
                including the fact that there is not a procedure that 
                reliably provides for the early detection of such 
                cancer;
                    ``(B) the fact that there may be a genetic basis to 
                such cancer;
                    ``(C) factors indicating a substantial risk of such 
                cancer; and
                    ``(D) the various treatments for such cancer and 
                the extent to which the treatments are effective; 
                and''.

SEC. 4. EFFECTIVE DATE.

    This Act takes effect October 1, 1995, or upon the date of the 
enactment of this Act, whichever occurs later.
                                 <all>
```